Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Sale of 5,000 TGTX shares, $274.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | TG THERAPEUTICS, INC. (TGTX) | Sale | 5,000 | $274.8K |
| Aug 7, 2026 | TG THERAPEUTICS, INC. (TGTX) | Gift | 5,100 | n/a |
| Jun 15, 2026 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 8,325 | n/a |
| Jan 29, 2026 | TG THERAPEUTICS, INC. (TGTX) | Gift | 30,000 | n/a |
| Jun 16, 2025 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 21,408 | n/a |
| Mar 11, 2025 | TG THERAPEUTICS, INC. (TGTX) | Gift | 6,000 | n/a |
| Nov 12, 2024 | TG THERAPEUTICS, INC. (TGTX) | Sale | 25,000 | $754.9K |
| Jun 20, 2024 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 22,250 | n/a |
| Mar 13, 2024 | TG THERAPEUTICS, INC. (TGTX) | Sale | 22,000 | $351.3K |
| Jan 8, 2024 | TG THERAPEUTICS, INC. (TGTX) | Sale | 17,500 | $333.0K |